Elsevier B.V.

Elsevier is a Dutch academic publishing and analytics company specializing in scientific, technical, and medical (STM) content. Founded in 1880, its core mission is to advance science and healthcare by facilitating insights and critical decision-making for professionals across global research and health ecosystems. The company's headquarters are located in Amsterdam, Netherlands.

Elsevier offers a comprehensive portfolio of products and services, including prestigious journals such as The Lancet and Cell. Its key digital platforms include ScienceDirect, a leading collection of electronic journals and e-books; Scopus, a comprehensive citation database; SciVal, a research performance tool; and ClinicalKey, a search engine for clinicians. The company also provides digital tools for data management, instruction, research analytics, and assessment, serving a wide range of customers including academic and government institutions, corporate research labs, and healthcare professionals.

Led by CEO Kumsal Bayazit, Elsevier continues to innovate, with recent initiatives focusing on AI-powered solutions such as Osmosis AI, ClinicalKey AI, and LeapSpace to enhance learning and research. As a global leader in its field, Elsevier is a subsidiary of RELX Group plc, a publicly traded company. While its parent company reported strong financial results in 2024, Elsevier has faced criticism regarding its high profit margins and copyright practices, leading to some institutions re-evaluating their contracts.